511 filings
Page 8 of 26
DEFA14A
sra9yggxcn mmq55dd3u
29 Oct 21
Additional proxy soliciting materials
10:07am
DEFA14A
22176 eqsk84bw
29 Oct 21
Additional proxy soliciting materials
10:05am
424B5
p1aks5aa
15 Oct 21
Prospectus supplement for primary offering
4:47pm
8-K
xfneu v5e0zk
15 Oct 21
OpGen Announces $15 Million Registered Direct Offering
4:31pm
8-K
neiyciy6xsdf22jrw8
4 Oct 21
OpGen Receives FDA Clearance for AcuitasĀ® AMR Gene Panel
8:10am
EFFECT
raumyq163k dzkeorl3
20 Aug 21
Notice of effectiveness
12:15am
CORRESP
9t53l jxlwss9rub
17 Aug 21
Correspondence with SEC
12:00am
UPLOAD
nzry4ydclt
16 Aug 21
Letter from SEC
12:00am
8-K
zc5v9mfpf93sjl9g9
12 Aug 21
OpGen Reports Second Quarter 2021 Financial Results and Provides Business Update
5:05pm
DEFA14A
qb2h6wv 0bk
5 Aug 21
Additional proxy soliciting materials
9:41am
8-K
kfyp8 7gs
5 Aug 21
OpGen Announces the Cancellation of Adjourned Portion of Annual Meeting
9:40am
8-K
0ye3ogpeb 5n2r
29 Jul 21
Departure of Directors or Certain Officers
4:47pm
DEFA14A
jdt4 3a944l
7 Jul 21
Additional proxy soliciting materials
5:23pm
8-K
veygjz
7 Jul 21
OpGen Announces Partial Adjournment of Annual Meeting
5:20pm
DEFA14A
dtbxo0m jmgy9g4220h
29 Jun 21
Additional proxy soliciting materials
5:30pm
EFFECT
td7q93mhw50wd1 949m
14 Jun 21
Notice of effectiveness
12:15am